Darlington Memorial Hospital is an acute NHS hospital providing healthcare for people living in southern County Durham, England. It is managed by the County Durham and Darlington NHS Foundation Trust.

There are 463 beds in Darlington Memorial Hospital.

During the past decade, Darlington Memorial Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Darlington Memorial Hospital" #1 sponsor was "University College, London" with 3 trials, followed by "County Durham and Darlington NHS Foundation Trust" with 2 trials sponsored, "Medical Research Council" with 2 trials sponsored, "Ottawa Hospital Research Institute" with 2 trials sponsored and "Sucampo Pharma Americas, LLC" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Darlington Memorial Hospital" #1 collaborator was "Academic Medical Organization of Southwestern Ontario" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Darlington Memorial Hospital" are "Colorectal Cancer" (2 trials), "Constipation - Functional" (2 trials), "Crohn Disease" (2 trials), "Lung Cancer" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Darlington Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Darlington Memorial Hospital" are "Drug" (16 trials), "Other" (2 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lubiprostone" (2 trials), "Placebo" (2 trials), "quality-of-life assessment" (2 trials), "5-ASA Withdrawal" (1 trials) and "ADT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Darlington Memorial Hospital" are 21 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Darlington Memorial Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Darlington Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Darlington Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".